Live tape
Top 8, mentions 7d24,064NVDA14,337 mentions▲ +0.04GOOGL2,074 mentions▲ +0.04MSFT1,623 mentions-0.02SPCX1,612 mentions▲ +0.07AAPL1,188 mentions▲ +0.03SPY1,140 mentions▲ +0.06QQQ1,070 mentions▲ +0.06AMD1,020 mentions▲ +0.08

Equity · Healthcare

HURA

NASDAQ

TuHURA Biosciences, Inc./NV (HURA)

2.25 USD +2.27% vs prior close
TuHURA Biosciences, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Market cap
148.0M USD
Revenue, year to Dec 2025
0 USD
EPS, diluted, year to Dec 2025
−0.63 USD
52-week range
0.4396 USD – 3.24 USD
Avg volume
122.2K

as of Jul 17, 2026

Have TuHURA Biosciences, Inc./NV (HURA) insiders bought or sold shares recently?

In the 90 days to 20 Nov 2026, no TuHURA Biosciences, Inc./NV insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4).

Form 4, 90 days to 20 Nov 2026, newest Form 4 filing 17 Nov 2026

0buys
0sells
1other filings
Have TuHURA Biosciences, Inc./NV (HURA) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Nov 2026Bianco James A.Chief Executive OfficerGift75,000

Which funds hold TuHURA Biosciences, Inc./NV (HURA)?

3 of the 45 institutional funds we track reported a TuHURA Biosciences, Inc./NV position for the quarter ended 30 Sep 2026 — a combined 953K USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold TuHURA Biosciences, Inc./NV (HURA)?
FundPositionSharesValueShares q/q
Millennium ManagementTrimmed281,328591K USD−38.1%
AQR Capital ManagementTrimmed110,891233K USD−73.9%
Citadel AdvisorsTrimmed61,717130K USD−73.4%
Tudor Investment CorpExited

Have members of Congress traded TuHURA Biosciences, Inc./NV (HURA)?

The most recent congressional trade disclosed in TuHURA Biosciences, Inc./NV is a purchase by Laurel M. Lee (house, FL), dated 25 Nov 2024.

STOCK Act disclosures

Have members of Congress traded TuHURA Biosciences, Inc./NV (HURA)?
TradedMemberTypeAmountFiled after
25 Nov 2024Laurel M. Leehouse · Republican–FLPurchase1K USD–15K USD43 days
18 Oct 2024Laurel M. Leehouse · Republican–FLExchange100K USD–250K USD34 days

What has been filed or recorded for TuHURA Biosciences, Inc./NV (HURA)?

The filings we hold for TuHURA Biosciences, Inc./NV, newest first: 14 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for TuHURA Biosciences, Inc./NV (HURA)?
And
30 Oct 2026Fails to deliverShares failed to deliver3,668 shares8K USD notional · 0.006% of shares out
29 Oct 2026Fails to deliverShares failed to deliver2,725 shares5K USD notional · 0.004% of shares out
28 Oct 2026Fails to deliverShares failed to deliver1,019 shares2K USD notional · 0.002% of shares out
27 Oct 2026Fails to deliverShares failed to deliver18,500 shares38K USD notional · 0.028% of shares out
23 Oct 2026Fails to deliverShares failed to deliver6,230 shares13K USD notional · 0.009% of shares out
20 Oct 2026Fails to deliverShares failed to deliver1,122 shares2K USD notional · 0.002% of shares out
19 Oct 2026Fails to deliverShares failed to deliver1,207 shares2K USD notional · 0.002% of shares out
16 Oct 2026Fails to deliverShares failed to deliver2,861 shares5K USD notional · 0.004% of shares out
14 Oct 2026Fails to deliverShares failed to deliver1,189 shares2K USD notional · 0.002% of shares out
13 Oct 2026Fails to deliverShares failed to deliver9,729 shares18K USD notional · 0.015% of shares out
09 Oct 2026Fails to deliverShares failed to deliver24,648 shares48K USD notional · 0.037% of shares out
08 Oct 2026Fails to deliverShares failed to deliver709 shares1K USD notional · 0.001% of shares out
07 Oct 2026Fails to deliverShares failed to deliver5,743 shares11K USD notional · 0.009% of shares out
06 Oct 2026Fails to deliverShares failed to deliver2,210 shares4K USD notional · 0.003% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.10 USD
30 Sep 2026FinancialsTotal assets36.2M USDat period end
30 Sep 2026FinancialsTotal equity19.0M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.14 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.13 USD
31 Dec 2025Annual reportFY 2025 reportedEPS −0.63 USD
31 Dec 2025FinancialsRevenue0 USDfiscal year
31 Dec 2025FinancialsNet income−30.1M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.63 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.14 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.21 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.15 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −1.21 USD

What do people ask about TuHURA Biosciences, Inc./NV (HURA)?

From live data
What is TuHURA Biosciences, Inc./NV’s market cap?148.0M

TuHURA Biosciences, Inc./NV is worth 148.0M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is TuHURA Biosciences, Inc./NV’s revenue?0

TuHURA Biosciences, Inc./NV reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have TuHURA Biosciences, Inc./NV insiders bought or sold shares recently?1 filing

In the 90 days to 20 Nov 2026, no TuHURA Biosciences, Inc./NV insider bought or sold shares on the open market; the 1 Form 4 filing in that window was a grant, exercise, tax withholding or transfer (SEC Form 4). See Insiders

Which funds own TuHURA Biosciences, Inc./NV?3 of 45

3 of the 45 funds we track reported a TuHURA Biosciences, Inc./NV position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, AQR Capital Management and Citadel Advisors. See Funds

Have members of Congress traded TuHURA Biosciences, Inc./NV?2 trades

Yes. 2 trades in TuHURA Biosciences, Inc./NV appear in the congressional disclosures we hold; the latest is a purchase by Laurel M. Lee (House, FL) dated 25 Nov 2024, filed 7 Jan 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did TuHURA Biosciences, Inc./NV last report earnings?−0.10

TuHURA Biosciences, Inc./NV last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.10 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. Wikimedia CommonsPortraits via Wikimedia Commons. Laurel M. Lee: Government of Florida, Public domain.
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data
  8. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  9. SEC EDGARreported earnings figures and scheduled report dates
  10. SEC EDGARValuation computed from SEC EDGAR filings
  11. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words